Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 25 Sept, 01:30 am

Apple (NASDAQ: AAPL) Remains a Major Institutional Holding, but Filings Show Mixed Changes Apple Inc. (NASDAQ: AAPL) closed at $339.75 on September 22, 2026, with a market capitalization of approximately $4.96 trillion . These are dated figures, not a current quote. Robinhood Ass

Strong Q1 Financial Performance: Paychex, Inc. (NASDAQ:PAYX) exceeded expectations with an adjusted EPS of $1.34 and total revenue of $1.63 billion , demonstrating robust growth. Key Segment Growth: Performance was fueled by significant growth in the Professional Employer Organiz

RBC Capital issued a "Sector Perform" rating for Fastly, indicating a neutral investment outlook. Fastly targets significant revenue growth to $1.1 billion - $1.3 billion by 2029, supported by consistent operational improvements and a large total addressable market. The company i

Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL) significantly surpassed analyst earnings per share (EPS) estimates, reporting $0.99 per share against a $0.17 consensus, driving positive stock performance . The restaurant and retail company also exceeded quarterly revenue exp

Guggenheim analyst Steven Forbes adjusted the price target for AutoZone (NYSE: AZO) to $3,750 , indicating a potential upside of 29.55% from its previous trading price of $2,894.73 . AutoZone reported mixed fourth-quarter results , with sales reaching $6.6 billion (a 5.6% increas

General Mills (NYSE:GIS) exceeded analyst expectations for both earnings per share (EPS) and revenue in its fiscal first quarter. Despite strong top-line performance, General Mills reported a significant decline in overall profit compared to the previous year. General Mills (NYSE

Analyst Jefferies raised Amgen (NASDAQ:AMGN) 's price target to $410.00 , reflecting confidence in its future prospects. Amgen's experimental drug, dazodalibep, successfully met its primary goal in a late-stage clinical trial for Sjögren's disease. Following the positive news, Am

Citizens Maintains Outperform Rating on KB Home (NYSE: KBH) but Cuts Price Target Analyst rating: Citizens maintained its Market Outperform rating on KB Home (NYSE: KBH) on September 23, 2026, while lowering its price target from $77 to $70 . Mixed third-quarter results: Earnings

Worthington Enterprises (NYSE:WOR) significantly surpassed analyst earnings estimates, reporting $0.82 per share against a $0.75 consensus for Q1 fiscal 2027. The company achieved robust revenue growth, posting $343.90 million , which exceeded estimates and marked a substantial 1

Seaport Global initiated coverage on Marvell Technology with a "Buy" rating and a price target of $270.00 , indicating a 2.91% upside. Marvell Technology's new 2-nanometer optical interconnects are set to enhance AI data center connectivity, driving recent stock gains. Despite a

BMO Capital has initiated coverage on HCA Healthcare with an Outperform rating and a price target of $495.00 , suggesting a potential 12.98% upside. Despite challenges from expiring exchange tax credits impacting payer mix, HCA Healthcare demonstrates solid underlying demand with

Viking Therapeutics (NASDAQ: VKTX) Surges on Strong VK2735 Obesity Drug Data Viking Therapeutics (NASDAQ: VKTX) surged after new VK2735 data showed strong weight-loss maintenance with less frequent dosing. VK2735 produced about 16% to 19% weight loss after 21 weeks, with some lon

BMO Capital initiated coverage on Tenet Healthcare with a "Market Perform" rating, suggesting its stock performance is expected to align with broader market trends. Tenet Healthcare is forecasted to report a significant 24.05% increase in Earnings Per Share (EPS) to $4.59 , indic

Market Movers: Jaguar Health, Greenland Mines, and Viking Therapeutics Lead Gains Jaguar Health (NASDAQ: JAGX) surged after receiving FDA fee waivers for Mytesi and Canalevia-CA1. Greenland Mines (NASDAQ: GRML) continued to rally on Greenland-related strategic metals interest. Vi

Market Downturn: Top Stock Losers and Key Drivers New Fortress Energy (NASDAQ: NFE) led the declines, falling about 24.7% . Xanadu Quantum Technologies (NASDAQ: XNDU) dropped sharply as quantum stocks remained volatile. Other major losers included Twin Vee Powercats (NASDAQ: VEEE

Capri Holdings (NYSE: CPRI): Analyst Hold Rating Amid Takeover Uncertainty and Growth Prospects Analyst firm Jefferies (NYSE: JEF) has maintained a ' Hold ' rating on Capri Holdings, citing uncertainty surrounding a potential takeover as the primary reason. Despite market uncerta

H.C. Wainwright upgraded Celldex to a Buy rating, raising its price target to $64.00 from $42.00 . The upgrade follows successful Phase 3 clinical trials for barzolvolimab, a drug targeting a chronic skin condition. Celldex is preparing for a 2027 FDA submission, highlighting sig

MillerKnoll exceeded profit expectations , reporting a strong earnings per share (EPS) of $0.53 , significantly above analyst estimates. Despite the profit beat, the company's revenue of $923.40 million fell short of targets, primarily due to softer activity in its North America
Headlines provided by Investing.com